PARAGANGLIOMA/ PHAEOCHROMOCYTOMA

Clinical trials for PARAGANGLIOMA/ PHAEOCHROMOCYTOMA explained in plain language.

Never miss a new study

Get alerted when new PARAGANGLIOMA/ PHAEOCHROMOCYTOMA trials appear

Sign up with your email to follow new studies for PARAGANGLIOMA/ PHAEOCHROMOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Promising combo therapy for childhood cancers enters human trials

Disease control Recruiting now

This study tests a combination of two drugs—Lutathera (a targeted radiation therapy) and olaparib (a PARP inhibitor)—in children and teens aged 3 to 18 with solid tumors that have come back or not responded to standard treatment. The goal is to find the safest dose and see if the…

Matched conditions: PARAGANGLIOMA/ PHAEOCHROMOCYTOMA

Phase: PHASE1, PHASE2 • Sponsor: Fundación de investigación HM • Aim: Disease control

Last updated May 18, 2026 12:00 UTC

PARAGANGLIOMA/ PHAEOCHROMOCYTOMA

Get alerted when new PARAGANGLIOMA/ PHAEOCHROMOCYTOMA trials appear

Promising combo therapy for childhood cancers enters human trials